目錄號： 100102
請?zhí)顚懩脑u價
關(guān)鍵信息
Liquid, may turn slightly opaque during stroage
Human
FIA
產(chǎn)品概述
| 產(chǎn)品名稱 | Anti-h PSA 8301 SPRN-5 |
|---|---|
| 目錄號 | 100102 |
| 描述 | Monoclonal mouse antibody, cultured in vitro under conditions free from animal-derived components. |
| 應(yīng)用 | FIA, 若需了解更多應(yīng)用，請聯(lián)系我們 |
補充說明
| 劑型/外觀 | Liquid, may turn slightly opaque during stroage |
|---|---|
| 濃度 | 5.0 mg/ml (+/- 10 %) |
| 備注 | Clone 8301 reacts with non-reduced and reduced intact PSA but not with reduced PSA fragments (Rye et al., 1999). In the same study affinities for free-PSA and PSA-ACT-complex were, 9.0 x 10-9 mol/l and 5.2 x 10-9, respectively. They also noted that antibodies binding to epitope group 3a form a good pair with antibodies from groups 1, 5a, 5c and 6. Clone 8301 does not cross-react with human kallikrein-2 (Black, 1999b). |
| 抗體亞型 | IgG1 |
| 克隆性質(zhì) | Monoclonal |
| 抗原決定簇 | Residues 158–163, group 3 as described in Rye et al. (1999) |
| 純度 | ≥ 95 % |
| 親和常數(shù) | KA= 1 x 1011 1/M |
| 相關(guān)產(chǎn)品 | Native PSA antigen, Lee Biosolutions 497-11 and 497-17 |
| 緩沖液 | 37 mM citrate, 125 mM phosphate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| 等電聚焦圖譜 | 6.5–7.2 |
| 交叉反應(yīng) | PSA/α1-ACT complex 59 %, Kallikrein < 0.04 %, PAP < 0.04 % |
| 特異性 | Antibody recognizes human prostate-specific antigen |
儲運條件
| 儲存條件 | +2-8°C |
|---|---|
| 運輸條件 | Cold packs |
| 庫存及貨期 | 小包裝樣品現(xiàn)貨 |
| 有效期 | 36 months |
參考文獻(xiàn)
| 文獻(xiàn) | Black, M.H., Grass, C.L., Leinonen, J., Stenman, U-H. and Diamandis, E.P., (1999a) Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays. Clin. Chem., 45(3):347-354 Black, M.H., Magklara, A., Obiezu, C.V., Melegos, D.N. and Diamandis, E.P., (1999b) Development of an ultrasensitive immuoassay for human glandular kallikrein with no crossreactivity from prostate-specific antigen. Clin. Chem., 45(6):790-799 Ferguson, R.A., Yu, H., Kalyvas, M., Zammit, S. and Diamandis, E.P., (1996) Ultrasensitive detection of prostate-specific antigen by time-resolved immunofluorometric assay and the Immulite? immunochemiluminescent third-generation assay: potential applications in prostate and breast cancer. Clin. Chem., 42(5):675-684 Magklara, A., Scorilas, A., López-Otín, C., Vizoso, F., Ruibal, A. and Diamandis, E.P., (1999) Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. Clin. Chem., 45(10):1774-1780 Obiezu, C.V., Giltay, E.J., Magklara, A., Scorilas, A., Gooren, L.J.G., Yu, H., Howarth, D.J.C. and Diamandis, E.P., (2000) Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin. Chem., 46(6):859-862 Rye, P.D., Bormer, O.P. and Paus, E. (guest editors) (1999), ISOBM TD-3 International Workshop on monoclonal antibodies against prostate-specific antigen. Tumor Biol., 20(suppl 1):1-94 |
|---|
評價
